Gp05 Modulates MRSA Membrane Phospholipids and Decreases Antimicrobial Sensitivity
Overview
The prophage-encoded protein Gp05 in MRSA downregulates the GraSR regulatory system and its downstream genes, altering membrane phospholipid composition. This modification increases MRSA resistance to antimicrobial peptides, neutrophils, and vancomycin, contributing to persistent infections.
Background
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of persistent endovascular infections such as bacteremia and infective endocarditis, with treatment failure rates around 30% despite antibiotic susceptibility. Persistent bacteremia, defined by prolonged positive blood cultures despite therapy, affects 15%–30% of MRSA cases and represents a distinct clinical challenge. The prophage-encoded protein Gp05 has been implicated as a virulence factor promoting MRSA persistence during vancomycin treatment, but the molecular mechanisms remain unclear. Understanding these pathways is critical for developing targeted therapies to improve clinical outcomes.
Increased susceptibility to LL-37, neutrophils, vancomycin
Wild-Type and gp05-Complemented
Normal expression of GraSR system and downstream genes
Balanced phospholipid composition
Reduced susceptibility to antimicrobial agents
Key Findings
Gp05 expression downregulates the GraSR two-component regulatory system and downstream genes mprF and dltABCD in MRSA.
This downregulation leads to a shift in membrane phospholipid composition, specifically increased phosphatidylglycerol and decreased lysyl-phosphatidylglycerol.
Altered membrane phospholipids result in decreased negative surface charge, reducing susceptibility to cationic antimicrobial peptides like LL-37.
Gp05 presence enhances MRSA resistance to neutrophil killing and vancomycin treatment, promoting bacterial persistence.
RNA-seq and qRT-PCR analyses confirmed these gene expression changes in both clinical persistent bacteremia isolates and laboratory strains.
Clinical Implications
The identification of Gp05 as a modulator of MRSA membrane composition and antimicrobial sensitivity highlights a novel mechanism of persistence during vancomycin therapy. Targeting Gp05 or its regulatory pathways may enhance the efficacy of existing antibiotics and host immune responses. Clinicians should be aware that MRSA strains harboring prophage-encoded factors like Gp05 may exhibit persistence despite standard susceptibility profiles.
Conclusion
Gp05 is a critical prophage-encoded virulence factor that modifies MRSA membrane phospholipids via downregulation of the GraSR system, decreasing antimicrobial sensitivity and promoting persistence. These insights provide potential targets for therapeutic intervention in persistent MRSA infections.
References
Wang et al. 2024 -- Gp05, a Virulence Factor Encoded by Phages, Modifies Membrane Phospholipids and Decreases Antimicrobial Sensitivity in Methicillin-Resistant Staphylococcus aureus
